Exploring the Clinical Development of the Fatty Acid Binding Protein 5 (FABP5) inhibitor ART26.12
Time: 11:30 am
day: Conference Day One
Details:
- FABP5 inhibitors as strategies for increasing endocannabinoid tone leading to analgesia
- Update on recent phase 1 clinical data
- Consideration of next steps
